Module 1: Introduction & Inaugral address: Dr Shubhi from Medical Learning Hub welcomed all the participants, speakers and the panelist. The session was inaugrated by IMA Bengal State leaders Dr MA Kasem, Dr Tapan Biswas, Dr Shakil Akhtar and Dr Bibartan Saha.
Module 2: Invasive Fungal Infection: the global burden – are we prepared: Dr Arunaloke Chakrabarti discussed about the invasive fungal infection and its global burden. Key points of discussion were-
- Concern about invasive fungal infections
- Outbreaks reported due to rare yeast
- New host, new saprophytic fungi, & environment are making the situation complex
- C. auris infection & mucormycosis outbreak have drawn the attention
- Early diagnosis & prompt therapy can help in optimal management
- Training is required on diagnosis among lab workers & management among clinicians
- Infection control & antifungal stewardship would require separate stress
Module 3: Azole Resistance: is it for real: Dr. Subhrajyoti Bhowmick discussed about Azole resistance. Key points of discussion were:
- Antifungal Classification.
- Antifungal Mechanism.
- Azoles
- Types of Azole Resistance
- Azole resistance Global scenario-Aspergillus spp.
- Azole resistance In India.
- Impact of Azole resistance on clinical Management
Module 4: Burden of fungal infection in COPD patient & role of clinical examination: Dr Suresh Ramasubban talked about the burden of fungal infection in COPD. Key points of discussion were:
- Respiratory Fungal Infections
- Pulmonary Syndrome
- Fungal infections in COPD
- COPD patients are at risk for IPA and CPA
- IPA is diagnosed based on clinical suspicion and All AECOPD patients are at risk
- CPA is also not very uncommon in COPD
Module 5: Empirical antifungal therapy: what guidelines say and what happens in practice: Dr Subhash Todi discussed about Empirical antifungal therapy: what guidelines say and what happens in practice and why. Key points of discussion were:
- Suspected Invasive candidiasis
- Empiric antifungal therapy should be considered in critically ill patients with
- Risk factors for invasive candidiasis and no other known cause of fever
- Surrogate markers for invasive candidiasis
- Culture data from nonsterile sites
Module 6: Role of Posaconazole in management of invasive aspergillosis: Dr Judhajit Sengupta discussed in detail about the role of Posaconazole for treating aspergillosis. Key points of discussion were:
- what is IA
- Risk Factors of IA
- How to treat IA – recommended antifungals
- Posaconazole – brief introduction/ MOA/PK-PD/ dosage
- Role of Posaconazole in IA – diff aspects
- Voriconazole vs Posaconazole
Module 7: Management of Fluconazole resistant Candida (with special emphasis on symptomatic candiduria): Dr. Sankar Sengupta discussed about the manangement of Flucanazole resistant Candida. Key points of discussion were:
- Urinary Tract involvement by invasive mycoses
- Candida
- risk factors for candiduria
- Pathogenesis
- Imaging Studies
- The emergence of drug resistance can be considered an inevitable consequence of the selective pressures imposed by antifungal drugs
Module 8: Question and Answer: This session was moderated by Dr Atri Gangopadhyay.Several questions were asked from speaker like:
- Could you summarise why global burden of INVASIVE Fungal Infections are rising compared to Fungal colonization with special reference to our Country?
- What does it imply as action plan for epidemiologists, infectious disease specialists, Microbiologist and Public health specialists?
- Fungal colonization in immunecompromised
- Survivor of severe covid with lung sequel suffering Invasive Fungal infection
- Post surgical patient suffering Invasive Fungal infection
- Bronchoscopy sample positive for Fungal stain, awaiting culture report
Module 9: Vote of thanks: Dr Sachin Malhotra from Medical Learning Hub delivered vote of thanks
We wish you a great learning experience!
We thank Mylan pharmaceuticals Pvt Ltd- a Viatris company for supporting this CME.
- Registration & Tea (5-5:30 PM)
- Introduction: (5:30-6:00PM)
- Introduction & Moderation
- Inaugural address by Host
Dr. Nirmal Maji
Dr. Santanu Sen
- Session 1: Invasive Fungal Infection – the global burden – are we prepared by Dr Dr Arunaloke Chakrabarti (6-6:30 PM)
- Session 2: Burden of fungal infection in COPD patient & role of clinical examination by Dr Suresh Ramasubban (6:30-7:00 PM)
- Session 3: Empirical antifungal therapy: what guidelines say and what happens in practice by Dr Subhash Todi (7-7:30 PM)
- Session 4: Role of Posaconazole in management of invasive aspergillosis by Dr Judhajit Sengupta (7:30-8:00 PM)
- Session 5: Azole Resistance – is it for real by Dr. Subhrajyoti Bhowmick (8-8:30 PM)
- Session 6: Management of Fluconazole resistant Candida (with special emphasis on symptomatic candiduria) by Dr. Sankar Sengupta (8:30-9:00 PM)
- Panel discussion, Q & A: (9-9:30PM)
- Moderator: Dr Atri Gangopadhyay
- Dinner: (9:30 PM)
